Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    W. Lawrence Drew, MD, PhD

    TitleRecalled Faculty/Academic Specialist
    SchoolUCSF School of Medicine
    DepartmentLaboratory Medicine
    Address1600 Divisadero St, Mt Zion
    Phone415-885-7315

       Bibliographic 
       Publications
      Publications by year:
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      1. Drew WL, Liu C. Repopulation of ganciclovir-resistant cytomegalovirus by wild-type virus. Clin Transplant. 2012 Nov; 26(6):949-52.
        View in: PubMed
      2. Tun N, London N, Kyaw MK, Smithuis F, Ford N, Margolis T, Drew WL, Lewallen S, Heiden D. CMV retinitis screening and treatment in a resource-poor setting: three-year experience from a primary care HIV/AIDS programme in Myanmar. J Int AIDS Soc. 2011; 14:41.
        View in: PubMed
      3. Liu C, Schwartz BS, Vallabhaneni S, Nixon M, Chin-Hong PV, Miller SA, Chiu C, Damon L, Drew WL. Pandemic (H1N1) 2009 infection in patients with hematologic malignancy. Emerg Infect Dis. 2010 Dec; 16(12):1910-7.
        View in: PubMed
      4. Drew WL. Cytomegalovirus resistance testing: pitfalls and problems for the clinician. Clin Infect Dis. 2010 Mar 1; 50(5):733-6.
        View in: PubMed
      5. Ooi CY, Brandão LR, Zolpys L, De Angelis M, Drew W, Jones N, Ling SC, Fecteau A, Ng VL. Thrombotic events after pediatric liver transplantation. Pediatr Transplant. 2010 Jun; 14(4):476-82.
        View in: PubMed
      6. Burbelo PD, Issa AT, Ching KH, Exner M, Drew WL, Alter HJ, Iadarola MJ. Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies. Virol J. 2009; 6:45.
        View in: PubMed
      7. Drew WL. Valacyclovir to reduce transmission of genital herpes simplex virus infection. J Infect Dis. 2009 Mar 15; 199(6):916.
        View in: PubMed
      8. Chiu CY, Urisman A, Greenhow TL, Rouskin S, Yagi S, Schnurr D, Wright C, Drew WL, Wang D, Weintrub PS, Derisi JL, Ganem D. Utility of DNA microarrays for detection of viruses in acute respiratory tract infections in children. J Pediatr. 2008 Jul; 153(1):76-83.
        View in: PubMed
      9. Heiden D, Ford N, Wilson D, Rodriguez WR, Margolis T, Janssens B, Bedelu M, Tun N, Goemaere E, Saranchuk P, Sabapathy K, Smithuis F, Luyirika E, Drew WL. Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med. 2007 Dec; 4(12):e334.
        View in: PubMed
      10. Drew WL, Roback JD. Prevention of transfusion-transmitted cytomegalovirus: reactivation of the debate? Transfusion. 2007 Nov; 47(11):1955-8.
        View in: PubMed
      11. Drew WL. Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients. Curr Opin Infect Dis. 2007 Aug; 20(4):408-11.
        View in: PubMed
      12. Marfori JE, Exner MM, Marousek GI, Chou S, Drew WL. Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients. J Clin Virol. 2007 Feb; 38(2):120-5.
        View in: PubMed
      13. Drew WL, Miner RC, Marousek GI, Chou S. Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet. J Clin Virol. 2006 Oct; 37(2):124-7.
        View in: PubMed
      14. Drew WL. Is combination antiviral therapy for CMV superior to monotherapy? J Clin Virol. 2006 Apr; 35(4):485-8.
        View in: PubMed
      15. Roback JD, Conlan M, Drew WL, Ljungman P, Nichols WG, Preiksaitis JK. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections. Transfus Med Rev. 2006 Jan; 20(1):45-56.
        View in: PubMed
      16. Stein J, Louie J, Flanders S, Maselli J, Hacker JK, Drew WL, Gonzales R. Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the detection of influenza infection in a community sample of adults. Ann Emerg Med. 2005 Nov; 46(5):412-9.
        View in: PubMed
      17. Louie JK, Hacker JK, Gonzales R, Mark J, Maselli JH, Yagi S, Drew WL. Characterization of viral agents causing acute respiratory infection in a San Francisco University Medical Center Clinic during the influenza season. Clin Infect Dis. 2005 Sep 15; 41(6):822-8.
        View in: PubMed
      18. Drew WL. I wish to comment on several points in the recent "Guidelines". J Clin Virol. 2005 May; 33(1):79.
        View in: PubMed
      19. Flanders SA, Stein J, Shochat G, Sellers K, Holland M, Maselli J, Drew WL, Reingold AL, Gonzales R. Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough. Am J Med. 2004 Apr 15; 116(8):529-35.
        View in: PubMed
      20. Imai Y, Shum C, Martin DF, Kuppermann BD, Drew WL, Margolis TP. Emergence of drug-resistant cytomegalovirus retinitis in the contralateral eyes of patients with AIDS treated with ganciclovir. J Infect Dis. 2004 Feb 15; 189(4):611-5.
        View in: PubMed
      21. Drew WL, Chou S, Mohr BA, Assmann SF, Miner RC, Laycock ME, Busch MP. Absence of activation of CMV by blood transfusion to HIV-infected, CMV-seropositive patients. Transfusion. 2003 Oct; 43(10):1351-7.
        View in: PubMed
      22. Chou S, Lurain NS, Thompson KD, Miner RC, Drew WL. Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. J Infect Dis. 2003 Jul 1; 188(1):32-9.
        View in: PubMed
      23. Roback JD, Drew WL, Laycock ME, Todd D, Hillyer CD, Busch MP. CMV DNA is rarely detected in healthy blood donors using validated PCR assays. Transfusion. 2003 Mar; 43(3):314-21.
        View in: PubMed
      24. Drew WL, Tegtmeier G, Alter HJ, Laycock ME, Miner RC, Busch MP. Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients. Transfusion. 2003 Mar; 43(3):309-13.
        View in: PubMed
      25. Lalezari JP, Aberg JA, Wang LH, Wire MB, Miner R, Snowden W, Talarico CL, Shaw S, Jacobson MA, Drew WL. Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding. Antimicrob Agents Chemother. 2002 Sep; 46(9):2969-76.
        View in: PubMed
      26. Drew WL, Chou S, Miner RC, Mohr BA, Busch MP, van der Horst CM, Asmuth DM, Kalish LA. Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis. J Infect Dis. 2002 Jul 1; 186(1):114-7.
        View in: PubMed
      27. Lalezari JP, Friedberg DN, Bissett J, Giordano MF, Hardy WD, Drew WL, Hubbard LD, Buhles WC, Stempien MJ, Georgiou P, Jung DT, Robinson CA. High dose oral ganciclovir treatment for cytomegalovirus retinitis. J Clin Virol. 2002 Feb; 24(1-2):67-77.
        View in: PubMed
      28. Chou S, Waldemer RH, Senters AE, Michels KS, Kemble GW, Miner RC, Drew WL. Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir. J Infect Dis. 2002 Jan 15; 185(2):162-9.
        View in: PubMed
      29. Mousavi-Jazi M, Schloss L, Drew WL, Linde A, Miner RC, Harmenberg J, Wahren B, Brytting M. Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity. J Clin Virol. 2001 Dec; 23(1-2):1-15.
        View in: PubMed
      30. Drew WL, Paya CV, Emery V. Cytomegalovirus (CMV) resistance to antivirals. Am J Transplant. 2001 Nov; 1(4):307-12.
        View in: PubMed
      31. Henry SP, Miner RC, Drew WL, Fitchett J, York-Defalco C, Rapp LM, Levin AA. Antiviral activity and ocular kinetics of antisense oligonucleotides designed to inhibit CMV replication. Invest Ophthalmol Vis Sci. 2001 Oct; 42(11):2646-51.
        View in: PubMed
      32. Roback JD, Hillyer CD, Drew WL, Laycock ME, Luka J, Mocarski ES, Slobedman B, Smith JW, Soderberg-Naucler C, Todd DS, Woxenius S, Busch MP. Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors. Transfusion. 2001 Oct; 41(10):1249-57.
        View in: PubMed
      33. Para MF, Kalish LA, Collier AC, Murphy EL, Drew WL. Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion. J Infect Dis. 2001 Jun 1; 183(11):1673-7.
        View in: PubMed
      34. Para MF, Kalish LA, Collier AC, Pollard RB, Kumar PN, Mintz L, Wallach FR, Drew WL. Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions. J Acquir Immune Defic Syndr. 2001 Apr 1; 26(4):320-5.
        View in: PubMed
      35. Nichols WG, Corey L, Gooley T, Drew WL, Miner R, Huang M, Davis C, Boeckh M. Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes. Blood. 2001 Feb 15; 97(4):867-74.
        View in: PubMed
      36. Chou S, Miner RC, Drew WL. A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance. J Infect Dis. 2000 Dec; 182(6):1765-8.
        View in: PubMed
      37. Drew WL. Ganciclovir resistance: a matter of time and titre. Lancet. 2000 Aug 19; 356(9230):609-10.
        View in: PubMed
      38. Landry ML, Stanat S, Biron K, Brambilla D, Britt W, Jokela J, Chou S, Drew WL, Erice A, Gilliam B, Lurain N, Manischewitz J, Miner R, Nokta M, Reichelderfer P, Spector S, Weinberg A, Yen-Lieberman B, Crumpacker C. A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. Antimicrob Agents Chemother. 2000 Mar; 44(3):688-92.
        View in: PubMed
      39. O'Sullivan CE, Drew WL, McMullen DJ, Miner R, Lee JY, Kaslow RA, Lazar JG, Saag MS. Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy. J Infect Dis. 1999 Sep; 180(3):847-9.
        View in: PubMed
      40. Drew WL, Stempien MJ, Andrews J, Shadman A, Tan SJ, Miner R, Buhles W. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir. J Infect Dis. 1999 Jun; 179(6):1352-5.
        View in: PubMed
      41. Drew WL, Lalezari JP. Cytomegalovirus: disease syndromes and treatment. Curr Clin Top Infect Dis. 1999; 19:16-29.
        View in: PubMed
      42. Cherrington JM, Fuller MD, Lamy PD, Miner R, Lalezari JP, Nuessle S, Drew WL. In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome. J Infect Dis. 1998 Dec; 178(6):1821-5.
        View in: PubMed
      43. Drew WL. Condoms and the transmission of cytomegalovirus. Sex Transm Dis. 1998 Oct; 25(9):481-2.
        View in: PubMed
      44. Chou S, Marousek G, Parenti DM, Gordon SM, LaVoy AG, Ross JG, Miner RC, Drew WL. Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy. J Infect Dis. 1998 Aug; 178(2):526-30.
        View in: PubMed
      45. Whitley RJ, Jacobson MA, Friedberg DN, Holland GN, Jabs DA, Dieterich DT, Hardy WD, Polis MA, Deutsch TA, Feinberg J, Spector SA, Walmsley S, Drew WL, Powderly WG, Griffiths PD, Benson CA, Kessler HA. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med. 1998 May 11; 158(9):957-69.
        View in: PubMed
      46. Sande MA, Armstrong D, Corey L, Drew WL, Gilbert D, Moellering RC, Smith LG. Perspectives on switching oral acyclovir from prescription to over-the-counter status: report of a consensus panel. Clin Infect Dis. 1998 Mar; 26(3):659-63.
        View in: PubMed
      47. Deeks SG, Collier A, Lalezari J, Pavia A, Rodrigue D, Drew WL, Toole J, Jaffe HS, Mulato AS, Lamy PD, Li W, Cherrington JM, Hellmann N, Kahn J. The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial. J Infect Dis. 1997 Dec; 176(6):1517-23.
        View in: PubMed
      48. Chernoff DN, Miner RC, Hoo BS, Shen LP, Kelso RJ, Jekic-McMullen D, Lalezari JP, Chou S, Drew WL, Kolberg JA. Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay. J Clin Microbiol. 1997 Nov; 35(11):2740-4.
        View in: PubMed
      49. Lalezari J, Schacker T, Feinberg J, Gathe J, Lee S, Cheung T, Kramer F, Kessler H, Corey L, Drew WL, Boggs J, McGuire B, Jaffe HS, Safrin S. A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS. J Infect Dis. 1997 Oct; 176(4):892-8.
        View in: PubMed
      50. Chou S, Marousek G, Guentzel S, Follansbee SE, Poscher ME, Lalezari JP, Miner RC, Drew WL. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. J Infect Dis. 1997 Sep; 176(3):786-9.
        View in: PubMed
      51. Flood J, Drew WL, Miner R, Jekic-McMullen D, Shen LP, Kolberg J, Garvey J, Follansbee S, Poscher M. Diagnosis of cytomegalovirus (CMV) polyradiculopathy and documentation of in vivo anti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays. J Infect Dis. 1997 Aug; 176(2):348-52.
        View in: PubMed
      52. Lalezari JP, Stagg RJ, Kuppermann BD, Holland GN, Kramer F, Ives DV, Youle M, Robinson MR, Drew WL, Jaffe HS. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med. 1997 Feb 15; 126(4):257-63.
        View in: PubMed
      53. Rasmussen L, Hong C, Zipeto D, Morris S, Sherman D, Chou S, Miner R, Drew WL, Wolitz R, Dowling A, Warford A, Merigan TC. Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis. 1997 Jan; 175(1):179-84.
        View in: PubMed
      54. van der Meer JT, Drew WL, Bowden RA, Galasso GJ, Griffiths PD, Jabs DA, Katlama C, Spector SA, Whitley RJ. Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection. Antiviral Res. 1996 Nov; 32(3):119-40.
        View in: PubMed
      55. Drew WL. Cytomegalovirus resistance to antiviral therapies. Am J Health Syst Pharm. 1996 Apr 15; 53(8 Suppl 2):S17-23.
        View in: PubMed
      56. Cherrington JM, Miner R, Hitchcock MJ, Lalezari JP, Drew WL. Susceptibility of human cytomegalovirus to cidofovir is unchanged after limited in vivo exposure to various regimens of drug. J Infect Dis. 1996 Apr; 173(4):987-92.
        View in: PubMed
      57. Lalezari JP, Stagg RJ, Jaffe HS, Hitchcock MJ, Drew WL. A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC). Adv Exp Med Biol. 1996; 394:105-15.
        View in: PubMed
      58. Drew WL, Ives D, Lalezari JP, Crumpacker C, Follansbee SE, Spector SA, Benson CA, Friedberg DN, Hubbard L, Stempien MJ, et al. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group. N Engl J Med. 1995 Sep 7; 333(10):615-20.
        View in: PubMed
      59. Flood J, Mintz L, Jay M, Taylor F, Drew WL. Hantavirus infection following wilderness camping in Washington State and northeastern California. West J Med. 1995 Aug; 163(2):162-4.
        View in: PubMed
      60. Chou S, Guentzel S, Michels KR, Miner RC, Drew WL. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis. 1995 Jul; 172(1):239-42.
        View in: PubMed
      61. Kimberlin DW, Crumpacker CS, Straus SE, Biron KK, Drew WL, Hayden FG, McKinlay M, Richman DD, Whitley RJ. Antiviral resistance in clinical practice. Antiviral Res. 1995 Apr; 26(4):423-38.
        View in: PubMed
      62. Lalezari JP, Drew WL, Glutzer E, James C, Miner D, Flaherty J, Fisher PE, Cundy K, Hannigan J, Martin JC, et al. (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J Infect Dis. 1995 Apr; 171(4):788-96.
        View in: PubMed
      63. Drew WL, Anderson R, Lang W, Miner RC, Davis G, Lalezari J. Failure of high-dose oral acyclovir to suppress CMV viruria or induce ganciclovir-resistant CMV in HIV antibody positive patients. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Mar 1; 8(3):289-91.
        View in: PubMed
      64. Lalezari JP, Drew WL, Glutzer E, Miner D, Safrin S, Owen WF, Davidson JM, Fisher PE, Jaffe HS. Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS. J Infect Dis. 1994 Sep; 170(3):570-2.
        View in: PubMed
      65. Lifson AR, Olson R, Roberts SG, Poscher ME, Drew WL, Conant MA. Severe opportunistic infections in AIDS patients with late-stage disease. J Am Board Fam Pract. 1994 Jul-Aug; 7(4):288-91.
        View in: PubMed
      66. Drew WL, Miner R, Saleh E. Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals. Clin Diagn Virol. 1993 Aug; 1(3):179-85.
        View in: PubMed
      67. Shimozuma M, Drew WL, Miner RC, Epstein WL, Fukuyama K. Direct inactivation of herpes simplex virus type-2 by rat epidermal protein. Antiviral Res. 1992 Jun; 18(2):179-89.
        View in: PubMed
      68. Drew WL. Nonpulmonary manifestations of cytomegalovirus infection in immunocompromised patients. Clin Microbiol Rev. 1992 Apr; 5(2):204-10.
        View in: PubMed
      69. Drew WL. Cytomegalovirus infection in patients with AIDS. Clin Infect Dis. 1992 Feb; 14(2):608-15.
        View in: PubMed
      70. Balfour HH, Drew WL, Hardy WD, Heinemann MH, Polsky B. Therapeutic algorithm for treatment of cytomegalovirus retinitis in persons with AIDS. A roundtable summary. J Acquir Immune Defic Syndr. 1992; 5 Suppl 1:S37-44.
        View in: PubMed
      71. Stanat SC, Reardon JE, Erice A, Jordan MC, Drew WL, Biron KK. Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob Agents Chemother. 1991 Nov; 35(11):2191-7.
        View in: PubMed
      72. Jacobson MA, Drew WL, Feinberg J, O'Donnell JJ, Whitmore PV, Miner RD, Parenti D. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. J Infect Dis. 1991 Jun; 163(6):1348-51.
        View in: PubMed
      73. Drew WL, Miner R, King D. Antiviral activity of FIAU (1-[2'deoxy-2'-fluoro-1-beta-D-arabinofuranosyl]-5-iodo-uridine) on strains of cytomegalovirus sensitive and resistant to ganciclovir. J Infect Dis. 1991 Jun; 163(6):1388-9.
        View in: PubMed
      74. Drew WL, Miner RC, Busch DF, Follansbee SE, Gullett J, Mehalko SG, Gordon SM, Owen WF, Matthews TR, Buhles WC, et al. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis. 1991 Apr; 163(4):716-9.
        View in: PubMed
      75. Drew WL. Clinical use of ganciclovir for cytomegalovirus infection and the development of drug resistance. J Acquir Immune Defic Syndr. 1991; 4 Suppl 1:S42-6.
        View in: PubMed
      76. Dworkin RJ, Drew WL, Miner RC, Mehalko S, Evans C, Baxter R. Survival of cytomegalovirus in viremic blood under blood bank storage conditions. J Infect Dis. 1990 Jun; 161(6):1310-1.
        View in: PubMed
      77. Baxter R, Chapman J, Drew WL. Comparison of bactericidal activity of five antibiotics against Staphylococcus aureus. J Infect Dis. 1990 May; 161(5):1023-5.
        View in: PubMed
      78. Drew WL, Blair M, Miner RC, Conant M. Evaluation of the virus permeability of a new condom for women. Sex Transm Dis. 1990 Apr-Jun; 17(2):110-2.
        View in: PubMed
      79. Rabella N, Drew WL. Comparison of conventional and shell vial cultures for detecting cytomegalovirus infection. J Clin Microbiol. 1990 Apr; 28(4):806-7.
        View in: PubMed
      80. Jespersen DJ, Drew WL, Gleaves CA, Meyers JD, Warford AL, Smith TF. Multisite evaluation of a monoclonal antibody reagent (Syva) for rapid diagnosis of cytomegalovirus in the shell vial assay. J Clin Microbiol. 1989 Jul; 27(7):1502-5.
        View in: PubMed
      81. Drew WL, Matthews TR. Susceptibility testing of herpes viruses. Clin Lab Med. 1989 Jun; 9(2):279-86.
        View in: PubMed
      82. Drew WL. Other virus infections in AIDS. I. Cytomegalovirus. Immunol Ser. 1989; 44:507-34.
        View in: PubMed
      83. Lang DJ, Drew WL. Cytomegalovirus and other herpes viruses. Transfus Med Rev. 1988 Dec; 2(4):294-5.
        View in: PubMed
      84. Drew WL. Cytomegalovirus infection in patients with AIDS. J Infect Dis. 1988 Aug; 158(2):449-56.
        View in: PubMed
      85. Drew WL. Diagnosis of cytomegalovirus infection. Rev Infect Dis. 1988 Jul-Aug; 10 Suppl 3:S468-76.
        View in: PubMed
      86. Drew WL, Buhles W, Erlich KS. Herpesvirus infections (cytomegalovirus, herpes simplex virus, varicella-zoster virus). How to use ganciclovir (DHPG) and acyclovir. Infect Dis Clin North Am. 1988 Jun; 2(2):495-509.
        View in: PubMed
      87. Drew WL, Mills J, Hauer LB, Miner RC, Rutherford GW. Declining prevalence of Kaposi's sarcoma in homosexual AIDS patients paralleled by fall in cytomegalovirus transmission. Lancet. 1988 Jan 2-9; 1(8575-6):66.
        View in: PubMed
      88. Drew WL. Diagnostic virology. Clin Lab Med. 1987 Dec; 7(4):721-40.
        View in: PubMed
      89. Gerberding JL, Bryant-LeBlanc CE, Nelson K, Moss AR, Osmond D, Chambers HF, Carlson JR, Drew WL, Levy JA, Sande MA. Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis. 1987 Jul; 156(1):1-8.
        View in: PubMed
      90. Drew WL. Is cytomegalovirus a cofactor in the pathogenesis of AIDS and Kaposi's sarcoma? Mt Sinai J Med. 1986 Dec; 53(8):622-6.
        View in: PubMed
      91. Drew WL. Controversies in viral diagnosis. Rev Infect Dis. 1986 Sep-Oct; 8(5):814-24.
        View in: PubMed
      92. Plotkin SA, Drew WL, Felsenstein D, Hirsch MS. Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine. J Infect Dis. 1985 Oct; 152(4):833-4.
        View in: PubMed
      93. Drew WL, Mills J, Lèvy J, Dylewski J, Casavant C, Ammann AJ, Brodie H, Merigan T. Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. Ann Intern Med. 1985 Jul; 103(1):61-3.
        View in: PubMed
      94. Drew WL. Cytomegalovirus infection in homosexual men--relationship to AIDS. Front Radiat Ther Oncol. 1985; 19:38-42.
        View in: PubMed
      95. Drew WL, Sweet ES, Miner RC, Mocarski ES. Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J Infect Dis. 1984 Dec; 150(6):952-3.
        View in: PubMed
      96. Katznelson S, Drew WL, Mintz L. Efficacy of the condom as a barrier to the transmission of cytomegalovirus. J Infect Dis. 1984 Jul; 150(1):155-7.
        View in: PubMed
      97. Abrams DI, Lewis BJ, Beckstead JH, Casavant CA, Drew WL. Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome? Ann Intern Med. 1984 Jun; 100(6):801-8.
        View in: PubMed
      98. Drew WL, Mintz L. What is the role of cytomegalovirus in AIDS? Ann N Y Acad Sci. 1984; 437:320-4.
        View in: PubMed
      99. Drew WL. Sexual transmission of CMV and its relationship to Kaposi sarcoma in homosexual men. Birth Defects Orig Artic Ser. 1984; 20(1):121-9.
        View in: PubMed
      100. Weintrub PS, Koerper MA, Addiego JE, Drew WL, Lennette ET, Miner R, Cowan MJ, Ammann AJ. Immunologic abnormalities in patients with hemophilia A. J Pediatr. 1983 Nov; 103(5):692-5.
        View in: PubMed
      101. Mintz L, Drew WL, Miner RC, Braff EH. Cytomegalovirus infections in homosexual men. An epidemiological study. Ann Intern Med. 1983 Sep; 99(3):326-9.
        View in: PubMed
      102. Mintz L, Drew WL. Sexually transmitted viral infections in homosexual men. Med Clin North Am. 1983 Sep; 67(5):1093-104.
        View in: PubMed
      103. Black SB, Raas M, Mintz L, Shinefield HR, Drew WL. Indirect hemagglutination inhibition: a direct method for detecting cytomegalovirus antigen. J Lab Clin Med. 1983 Mar; 101(3):450-2.
        View in: PubMed
      104. Ziegler JL, Drew WL, Miner RC, Mintz L, Rosenbaum E, Gershow J, Lennette ET, Greenspan J, Shillitoe E, Beckstead J, Casavant C, Yamamoto K. Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet. 1982 Sep 18; 2(8299):631-3.
        View in: PubMed
      105. Drew WL, Conant MA, Miner RC, Huang ES, Ziegler JL, Groundwater JR, Gullett JH, Volberding P, Abrams DI, Mintz L. Cytomegalovirus and Kaposi's sarcoma in young homosexual men. Lancet. 1982 Jul 17; 2(8290):125-7.
        View in: PubMed
      106. Follansbee SE, Busch DF, Wofsy CB, Coleman DL, Gullet J, Aurigemma GP, Ross T, Hadley WK, Drew WL. An outbreak of Pneumocystis carinii pneumonia in homosexual men. Ann Intern Med. 1982 Jun; 96(6 Pt 1):705-13.
        View in: PubMed
      107. Drew WL, Miner RC. Transfusion-related cytomegalovirus infection following noncardiac surgery. JAMA. 1982 May 7; 247(17):2389-91.
        View in: PubMed
      108. Bolan RK, Sands M, Schachter J, Miner RC, Drew WL. Lymphogranuloma venereum and acute ulcerative proctitis. Am J Med. 1982 Apr; 72(4):703-6.
        View in: PubMed
      109. Johnson MA, Drew WL, Roberts M. Branhamella (Neisseria) catarrhalis--a lower respiratory tract pathogen? J Clin Microbiol. 1981 Jun; 13(6):1066-9.
        View in: PubMed
      110. Drew WL, Mintz L, Miner RC, Sands M, Ketterer B. Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis. 1981 Feb; 143(2):188-92.
        View in: PubMed
      111. Mintz L, Drew WL. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1981 Feb; 19(2):332-4.
        View in: PubMed
      112. Mintz L, Drew WL. Relation of culture site to the recovery of nonpolio enteroviruses. Am J Clin Pathol. 1980 Sep; 74(3):324-6.
        View in: PubMed
      113. Drew WL, Mintz L. Rapid diagnosis of varicella-zoster virus infection by direct immunofluorescence. Am J Clin Pathol. 1980 May; 73(5):699-701.
        View in: PubMed
      114. Mintz L, Drew WL, Hoo R, Finley TN. Age-dependent resistance of human alveolar macrophages to herpes simplex virus. Infect Immun. 1980 May; 28(2):417-20.
        View in: PubMed
      115. Mintz L, Ballard RA, Sniderman SH, Roth RS, Drew WL. Nosocomial respiratory syncytial virus infections in an intensive care nursery: rapid diagnosis by direct immunofluorescence. Pediatrics. 1979 Aug; 64(2):149-53.
        View in: PubMed
      116. Montgomery K, Raymundo L, Drew WL. Chromogenic cephalosporin spot test to detect beta-lactamase in clinically significant bacteria. J Clin Microbiol. 1979 Feb; 9(2):205-7.
        View in: PubMed
      117. Drew WL, Mintz L, Hoo R, Finley TN. Growth of herpes simplex and cytomegalovirus in cultured human alveolar macrophages. Am Rev Respir Dis. 1979 Feb; 119(2):287-91.
        View in: PubMed
      118. Drew WL. Value of sputum culture in diagnosis of pneumococcal pneumonia. J Clin Microbiol. 1977 Jul; 6(1):62-5.
        View in: PubMed
      119. Drew WL, Finley TN, Mintz L, Klein HZ. Diagnosis of Pneumocystis carinii pneumonia by bronchopulmonary lavage. JAMA. 1974 Nov 4; 230(5):713-5.
        View in: PubMed
      120. Drew WL, Blume MR, Miner R, Silverberg I, Rosenbaum EH. Letter: Herpes zoster: transfer factor therapy. Ann Intern Med. 1973 Nov; 79(5):747-8.
        View in: PubMed
      121. Drew WL, Love R. Production of herpes simplex virus by HeLa cells treated with 5-fluoro-2'-deoxyuridine. Am J Pathol. 1968 Jul; 53(1):169-82.
        View in: PubMed
      W. Lawrence's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      See all (425) concept(s)
      _
      Co-Authors
      People in Profiles who have published with this person.
      See all (29) people
      _
      Related Authors
      People who share similar concepts with this person.
      See all (60) people
      _
      Same Department
      Search Department
      Back to TOP